Navigation Links
Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor
Date:5/13/2009

NERVIANO, Italy, May 13 /PRNewswire/ -- The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for the proliferation of cancer cells. This new compound is orally bioavailable, highly efficient and well tolerated in preclinical models of cancer after repeated dosing. This unique inhibitor adds another promising candidate to the pipeline of innovative cell cycle targets with different mechanisms of action in clinical development which have been discovered and developed by NMS. These include inhibitors of CDK, Aurora and CDC-7. An IND for an inhibitor of CDC-7 was approved by the FDA in January this year and the first patients were treated with the compound in April. NMS CDK and Aurora inhibitors are in phase I and II clinical development, respectively, and are starting to show promising activity in specific patient populations.

The clinical development path foresees application of the NMS PLK-1 inhibitor in solid and hematological indications. "I am pleased to see the second IND approval this year and I highly appreciate the consistant delivery of high quality clinical candidates by the Nerviano site" comments Dr. Francesco Colotta, VP R&D at NMS.

Nerviano Medical Sciences (NMS)

Nerviano Medical Sciences is the largest pharmaceutical R&D facility in Italy and one of the largest oncology-focused, integrated discovery and development companies in Europe. Research activities in Nerviano generate on average two clinical candidate molecules per year. NMS takes advantage of strategic alliances with biotechnology as well as pharmaceutical companies to secure its long term business sustainability. The Company has already finalized partnerships with major companies such as Pfizer Inc., Bristol-Myers Squibb C
'/>"/>

SOURCE Nerviano Medical Sciences
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical Announces First quarter 2009 results
2. China Sky One Medical, Inc. Schedules Conference Call to Discuss First Quarter 2009 Results
3. Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimers and Parkinsons Diseases at AAN Annual Meeting
4. Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
5. ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
6. University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
7. Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
8. Environmental Tectonics Corporation Expands BioMedical Systems Division Sales Staff
9. Nfocus Neuromedical Appoints Robert OHolla to Head Regulatory
10. Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing
11. BioMS Medical to present at Alberta Economic Forum in Geneva

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq...theNasdaqStockMarketthattradinginthecompany,scommo...5-NSEwillbefiledwiththe,SecuritiesandExchangeCommi...ngonNasdaq,unlessthecompanyfilesanappealtotheNasda...hanappeal,which,willstaythesuspensionanddelistingt...
(Date:11/24/2009)...wire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abi...cializingnovelpainmanagementtherapies,announcedtod...icer,isscheduledtopresentatthe21stAnnualPiperJaffr...heNewYorkPalaceHotelinNewYork,NewYork. ,, Mr.Di...lbeavailabletorespondtoquestionsduringthepresentat...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(T...derofadvancedlasersystemsandinstrumentsforthestemc...operationalandfinancialresultsforthethirdquarteren...ewas$1.46millioncomparedwith$1.43millioninQ32008,-...centinQ3,2008,-Netlossreducedto$148,000comparedto$...
(Date:11/24/2009)...nects Customers with Partners Validated to Process...oducts , Ottawa, ON (PRWE...rovider of products for biological sample collecti... its new global partner program. The program offer...er community and is designed to help partners scal...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...LOS ANGELES, Aug. 31 Signalife, Inc. (Amex:,SGN),...ecutive, has release,the following corporate updat... month: 1. Dr. Harmison has already "cleaned hous...ere producing no revenue whatsoever and no hope of...view. That was done immediately by Dr. Harmis...
...herapeutics, Inc.,announced today that it has file...curities and Exchange Commission for a proposed in...k. All of the shares in the proposed,offering will...f the offering will be Morgan Stanley & Co.,Incorp... and CIBC World,Markets Corp., Jefferies & Company...
...Allergy Testing in Managing Chronic ...0 Phadia US Inc. announced today,that The Nationa...has,issued an update on selected topics in the Gui.... Information in the guidelines reported that alle...ctors in the development,persistence and potential...
Other Biology Technology:Signalife Provides Corporate Update 2Signalife Provides Corporate Update 3ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering 2Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management 2
(Date:11/24/2009)...ay named 12 new grant recipients for 2009. The awa...ork across a broad spectrum of lupus research. All...potential to drive scientific discovery to ultimat...f systemic lupus. , The 2009 grants go to both n...tion and include interdisciplinary and highly prom...
(Date:11/24/2009)...e class of ring-shaped protein motors has been unc...ational Laboratory (Berkeley Lab) using a state-of...dvanced Light Source (ALS). These protein motors p...on, and are vital to the survival of all biologica... human papillomavirus, which has been linked to ce...
(Date:11/24/2009)...r of debate. A high-profile study a few years ago ... carbon from trees and leaves, evidence for a very...osystems. , But new research from the University.... Algae provide a much richer diet for fish and ot...this week in the Proceedings of the National Acad...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 1Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 2Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 3Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary Sanvita Inc 5309 1Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary Sanvita Inc 5309 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 1Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 3
...th a photograph that embodies the unexpected and ...rsity of Wisconsin-Madison graduate student Jenna ...ngineering Visualization Challenge, sponsored by t...e. , The image, "Polymazing," appears in the Sept...omewhat amazing, considering the subject of her ph...
...HILADELPHIA - Biophysicists at the University of P...d long-established data on cholesterol,s role in t...interaction between cholesterol and neurotransmitt...ehavior for the nicotinic acetylcholine receptor, ...lzheimer,s disease, Parkinson,s disease, schizophr...
...SHINGTON Members of the public can send their nam...st mission dedicated to understanding the effects ...bility on our climate. , The "Send Your Name Arou...rt in the science mission and place their names in...icipants can submit their information, is located ...
Other Biology News:UW science photo takes second in national contest 2Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue 2Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue 3Send your name around the Earth on NASA'S Glory mission 2
... Label IT siRNA Tracker Intracellular Localization...tly label and deliver siRNA, of your design, in an...o tracking experiments. Subcellular localization a... can be monitored following introduction of the la...
... Label IT siRNA Tracker Intracellular Localization...vides a straight forward approach to directly labe...nt yet non-destructive manner, for in vitro tracki...ional inhibition of target gene expression can be ...
...s kit allows for quick and reproducible immunoprec...e system is more reproducible than regular IPs, wh...otein A/G agarose without disrupting the agarose b... Catch and Release is reversible, and elution of t...
... Yeast Oligo Microarray Kit (V2), 2 x 11K will ena...ression of many thousands of yeast genes and ident...esses. Each microarray contains sequences represen... S288C strain of Saccharomyces cerevisiae, sourced...
Biology Products: